Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions (Q36771112)

16 August 2017

Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions (English)

1 reference

electronic health records

16 August 2017

1 reference

8

Carol Friedman

1 reference

16 August 2017

6

Nigam H Shah

1 reference

16 August 2017

Rave Harpaz

1

1 reference

16 August 2017

Santiago Vilar

2

1 reference

16 August 2017

William Dumouchel

3

1 reference

16 August 2017

Hojjat Salmasian

4

1 reference

16 August 2017

Krystl Haerian

5

1 reference

16 August 2017

Herbert S Chase

7

1 reference

16 August 2017

31 October 2012

1 reference

Journal of the American Medical Informatics Association

16 August 2017

1 reference

16 August 2017

20

1 reference

16 August 2017

3

1 reference

16 August 2017

413-419

1 reference

Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Using information mining of the medical literature to improve drug safety

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

A basic study design for expedited safety signal evaluation based on electronic healthcare data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Quantitative signal detection using spontaneous ADR reporting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Decision support methods for the detection of adverse events in post-marketing data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Early detection of adverse drug events within population-based health networks: application of sequential testing methods.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Novel statistical tools for monitoring the safety of marketed drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Data mining for signals in spontaneous reporting databases: proceed with caution

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

The role of data mining in pharmacovigilance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Automated encoding of clinical documents based on natural language processing

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Disproportionality methods for pharmacovigilance in longitudinal observational databases

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628045

Rhabdomyolysis and Myoglobinuria

5 September 2018

1 reference

12 December 2020

Predicting adverse drug events using pharmacological network models

1 reference

12 December 2020

Drug safety reform at the FDA--pendulum swing or systematic improvement?

1 reference

12 December 2020

Managing drug-risk information--what to do with all those new numbers

1 reference

12 December 2020

The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France

1 reference

12 December 2020

What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research

1 reference

12 December 2020

The New Sentinel Network — Improving the Evidence of Medical-Product Safety

1 reference

12 December 2020

An evaluation of computer-aided disproportionality analysis for post-marketing signal detection

1 reference

12 December 2020

1 reference

12 December 2020

Diagnosis and management of acute pancreatitis

1 reference

12 December 2020

10.1136/AMIAJNL-2012-000930

Identifiers

DOI

1 reference

journals/jamia/HarpazVDSHSCF13

16 August 2017

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference

16 August 2017

PubMed publication ID

23118093

1 reference